{% extends "base.html" %} {% block content %}

Developmental Neurotoxicity Risk Assessment of Silymarin

Question: Is there a risk of thyroid-mediated development neurotoxicity through MCT8 inhibition by silychristin when a pregnant woman takes silymarin supplements at a given dose, frequecy and duration (referring to the regulatory question 3a)?


This workflow is being implemented at this page at the moment, you can check out the webapplication here.

Steps to complete the workflow to answer the question:

  1. External Exposure Assessment: The tools that assess the magnitude, frequency, duration and exposure routes of a given exposure
  2. Internal Exposure: PBPK Modeling
  3. Hazard
  4. Report
{% endblock %}